These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2427840)

  • 1. A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S119-21. PubMed ID: 2427840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B; Rosenthal F; Taylor S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension.
    Trafford JA; Latta D; Little PS; Parsley J; Ankier SI; Quail D
    Curr Med Res Opin; 1989; 11(9):550-6. PubMed ID: 2533057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension.
    Kimura S; DeQuattro V; Hernandez PH; Lee DD
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):751-4. PubMed ID: 2971310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of celiprolol in the treatment of arterial hypertension].
    Belovezhdov N; Nachev Ch; Angelova I; Gergova V; Stefanov G
    Vutr Boles; 1985; 24(5):74-7. PubMed ID: 2868573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.
    Dorow P; Clauzel AM; Capone P; Mayol R; Mathieu M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S102-4. PubMed ID: 2427835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the Austrian celiprolol postmarketing surveillance study.
    Hoffmann W; Hoffmann H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S88-90. PubMed ID: 2427858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI; Jennings AA; Bateman ED; Opie LH
    Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
    Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.